Learn more

SHANGHAI MEIZER PHARMACEUTICALS CO LTD

Overview
  • Total Patents
    16
  • GoodIP Patent Rank
    102,385
About

SHANGHAI MEIZER PHARMACEUTICALS CO LTD has a total of 16 patent applications. Its first patent ever was published in 2018. It filed its patents most often in WIPO (World Intellectual Property Organization), China and United States. Its main competitors in its focus markets pharmaceuticals and organic fine chemistry are JENKEN BIOSCIENCES INC, ABBOTT HEALTHCARE PRODUCTS BV and VERNALIS R & D LTD.

Patent filings in countries

World map showing SHANGHAI MEIZER PHARMACEUTICALS CO LTDs patent filings in countries

Patent filings per year

Chart showing SHANGHAI MEIZER PHARMACEUTICALS CO LTDs patent filings per year from 1900 to 2020

Focus industries

Top inventors

# Name Total Patents
#1 Shu Yongzhi 16
#2 Lin Jun 2
#3 Luo Fengjun 1

Latest patents

Publication Filing date Title
WO2020177657A1 Chemical compound having btk-degrading activity
WO2021012659A1 Compound with androgen receptor degradation activity
CN109952304A One kind inhibits and the compound for the CDK that degrades
CN109963853A One kind has the degradation active compound of tyrosine protein kinase JAK3
WO2019042444A1 Compound for inhibiting and degrading tyrosine protein kinase alk
WO2019042445A1 Compound having bruton's tyrosine kinase (btk)-inhibition and degradation activity
CN109937203A One kind has inhibition and the active compound of tyrosine protein kinase JAK1 or JAK2 of degrading